Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2012

View Archived Issues

New GlyT1 inhibitors patented

Nuvilex provides information on cell encapsulation technology

New nanovector platform allows noncovalent assembly of targeted therapeutics

Promedior closes financing round to advance pipeline

Dr. Falk Pharma obtains European rights to ulcerative colitis drug candidate

Dendritic cell-based vaccine is safe in patients with HIV

Novartis transfers marketing rights for ophthalmic solution

Taiho Pharmaceutical terminates licensing agreement for antipruritic agent

Aegerion Pharmaceuticals provides update on lomitapide NDA

Moberg Derma receives clearance for phase I Limtop trial

New phosphodiesterase 10A inhibitors reported by Evotec

Shionogi & Co. presents novel P2X3 and P2X2/3 receptor antagonists

Avedro submits NDA for corneal cross-linking system

S&T Global designs novel candidate antivirals

New PARP-1 inhibitors with anticancer potential developed in China

Roche divulges new seprase-specific antibodies

Research at Glycotope results in new potential cancer immunotherapies

Novel candidate schizophrenia therapeutics identified

Novel RIPK2 inhibitors reported by GlaxoSmithKline

Roche describes novel potential cancer therapeutics

Janssen unblinds phase III Zytiga study

Teva and OncoGenex amend custirsen advanced prostate cancer program

BioMarin completes enrollment in phase III BMN-110 trial

Transparency Life Sciences in-licenses ACE inhibitor

Novo Nordisk seeks Japanese approval for insulin degludec/insulin aspart coformulation

Peregrine reports topline clinical data on bavituximab

Inviragen reports topline results from HFMD vaccine study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....